PFM Health Sciences’s MKS Inc MKSI Stock Holding History

PFM Health Sciences’s Portfolio MKSI Stock Details MKSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-301,611	Closed	-$27.8M	–	71
2019 Q3	$27.8M	Buy	+301,611	New	+$24.9M	0.82%	40

Other funds holding MKSI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PFM Health Sciences's MKSI Position: Q4 2019 in Review

PFM Health Sciences sold out of MKS Inc (MKSI) in Q4 2019, closing a stake of 301,611 shares — an estimated $27.8M sold.

PFM Health Sciences first reported a position in MKSI in Q3 2019 and held it in 1 quarter. The position peaked at $27.8M in Q3 2019. 350 funds tracked by Wall St. Rank hold MKSI as of Q4 2019.

PFM Health Sciences reported no remaining MKS Inc position as of Q4 2019 after selling out during the quarter.
PFM Health Sciences sold 301,611 MKS Inc shares in Q4 2019, an estimated $27.8M.
PFM Health Sciences first reported a position in MKS Inc in Q3 2019 and held it in 1 quarter.
PFM Health Sciences's MKS Inc position peaked at $27.8M in Q3 2019.
350 funds tracked by Wall St. Rank held MKS Inc as of Q4 2019.

Based on PFM Health Sciences's 13F filing for Q4 2019, filed 14 Feb 2020.